Le Lézard
Classified in: Health
Subject: MAT

John Patrick University (JPU) of Health and Applied Sciences Setting the Standard in Cannabinoid Medical Sciences Education and Training


SOUTH BEND, Ind., Nov. 25, 2020 /PRNewswire/ -- JPU is pleased to announce that it will be offering a Master's Degree in Integrative & Functional Medicine with a Concentration in Cannabinoid Medical Sciences starting in January 2021. The Cannabinoid Medical Sciences concentration is designed to foster understanding and a rational perspective for science-based healthcare providers, practitioners, educators, manufacturers, cultivators, and business operators.  JPU's faculty in this program consists of physicians, nurses, nutritionists, scientists, and data analytic specialists.  JPU caters to the working professional with flexible and accelerated online programs.

Michael Dubanewicz, Ed.D., CN, CCN, CFM, CDM, CFPP, Dean of the School of Integrative and Functional Medicine, notes "JPU is leading the change and future of health education to provide evidence-base study of cannabinoid medical sciences. Our curriculum provides both applied and clinical application of cannabinoids and its function within integrative health science." 

Mary Clifton, MD, Medical Director, is a board-certified, licensed, internal medicine doctor, and a recognized expert in cannabinoids and the endocannabinoid system. "This program will prepare you to give the most informed health advice to your patients and clients, helping them to receive the absolute best care available."

Janice Newell Bissex, MS, RDN, FAND leads as Co-Program Director for the Cannabinoid Medical Sciences concentration. "As a Holistic Cannabis Practitioner and Registered Dietitian Nutritionist, teaching about medical cannabis aligns with my mission to help those suffering from pain, anxiety, insomnia, autoimmune disorders, IBD/IBS, and other debilitating conditions find relief using CBD and cannabis."

John Patrick University (JPU) of Health and Applied Sciences is a progressive university with BS and MS degrees in the Radiological Sciences, Medical Imaging Sciences, Business and Data Sciences, and Integrative and Functional Medicine Disciplines (Lifestyle Medicine, Functional Nutrition, Sports Medicine, and Cannabinoid Medical Sciences).  

If you are interested in a degree with a focus on Cannabinoid Medical Sciences, please contact: [email protected], 888-578-4968

Accredited Member, ACCSC; AC-0027

Media Contact:
Michael Dubanewicz
954-649-0989
[email protected] 
https://jpu.edu/

SOURCE John Patrick University of Health and Applied Sciences


These press releases may also interest you

at 05:12
Sobi establishes MTN programme with a framework amount of SEK 10 billion, publishes a base prospectus
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...

at 02:48
RaySearch publishes Annual Report for 2023
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
ZINZINO AB (PUBL): NOTICE OF ANNUAL GENERAL MEETING IN ZINZINO AB ON MAY 27, 2024
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica publishes Annual Report 2023
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Interim report January-March 2024: Medicover
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

More news about Health...


News published on and distributed by: